ClinVar Miner

Submissions for variant NM_133433.4(NIPBL):c.2479_2480del (p.Arg827fs)

dbSNP: rs398124465
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000146547 SCV000193843 pathogenic Cornelia de Lange syndrome 1 2013-02-08 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000082485 SCV000225096 pathogenic not provided 2012-08-03 criteria provided, single submitter clinical testing
GeneDx RCV000082485 SCV000565326 pathogenic not provided 2022-11-28 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23760082, 16236812, 30158690, 36041635, 31337854, 31157197, 15318302, 20358602)
Baylor Genetics RCV000146547 SCV000747066 pathogenic Cornelia de Lange syndrome 1 2022-12-19 criteria provided, single submitter clinical testing
Invitae RCV000146547 SCV000934470 pathogenic Cornelia de Lange syndrome 1 2023-10-18 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg827Glyfs*2) in the NIPBL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NIPBL are known to be pathogenic (PMID: 15318302, 19763162, 23505322, 29995837). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Cornelia de Lange syndrome (PMID: 15318302, 17661813, 20358602, 20824775). ClinVar contains an entry for this variant (Variation ID: 96336). For these reasons, this variant has been classified as Pathogenic.
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV000146547 SCV001984850 pathogenic Cornelia de Lange syndrome 1 2020-06-02 criteria provided, single submitter clinical testing This frameshifting variant in exon 10 of 47 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a heterozygous change in multiple unrelated individuals with Cornelia de Lange Syndrome (CdLS, PMID: 15318302, 17661813, 20358602, 20824775, 30158690, 31157197). Cells lines from a CdLS patient carrying this variant exhibited chromatin decompaction (PMID: 23760082). In addition, gene expression studies on human induced pluripotent stem cells and cardiomyocytes derived in-vitro from a carrier of this variant identified altered expression of genes involved in multiple cellular processes and normal heart development (PMID: 29348408). It is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.2479_2480del (p.Arg827GlyfsTer2) variant is classified as Pathogenic.
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics RCV000146547 SCV001985071 pathogenic Cornelia de Lange syndrome 1 2018-03-20 criteria provided, single submitter clinical testing A heterozygous frameshift variation in exon 10 of the NIPBL gene that results in the termination of amino acid 2 codons downstream of Glycine at codon 827 was detected. The observed variant c.2479_2480delAG (p.Arg827GlyfsTer2) has not been reported in the 1000 gemomes, ExAC database. The in-silico prediction of the variant is disease causing by MutationTaster2. The reference codon is conserved across species. The segregation analysis showed this variation to be de novo in origin. In summary, the variant meets our criteria to be classified as a pathogenic variant.
Genome-Nilou Lab RCV000146547 SCV002055964 pathogenic Cornelia de Lange syndrome 1 2021-07-15 criteria provided, single submitter clinical testing
OMIM RCV000146547 SCV000022385 pathogenic Cornelia de Lange syndrome 1 2004-10-01 no assertion criteria provided literature only
Division of Human Genetics, National Health Laboratory Service/University of the Witwatersrand RCV000146547 SCV002552099 pathogenic Cornelia de Lange syndrome 1 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.